Q32 Bio (QTTB) Fundamental Analysis: Revenue, Earnings & Valuation

5.26 / 10

Netural

Fundamental score is 5.26/10, indicating balanced quality. Strong points include Asset‑MV, Profit‑MV, Cash‑MV and inventory turnover, which carry the highest weights. Revenue‑MV and gross margin are weaker, leading to a moderate overall fundamental outlook.

Analysis Checks(7/10)

Revenue-MV

Value1.74

Score1/3

Weight11.02%

1M Return5.44%

Inventory turnover ratio

Value106.57

Score3/3

Weight13.38%

1M Return6.65%

Gross profit margin (%)

Value100.00

Score1/3

Weight0.52%

1M Return0.36%

Profit-MV

Value3.14

Score2/3

Weight12.58%

1M Return6.36%

Income tax / Total profit (%)

Value0.00

Score1/3

Weight0.31%

1M Return0.21%

Current assets turnover ratio

Value0.78

Score2/3

Weight2.89%

1M Return1.91%

Fixed assets turnover ratio

Value8.16

Score3/3

Weight2.67%

1M Return1.76%

Cost of sales ratio (%)

Value57.03

Score3/3

Weight6.65%

1M Return4.08%

Asset-MV

Value-0.55

Score3/3

Weight37.65%

1M Return15.70%

Cash-MV

Value0.03

Score2/3

Weight12.33%

1M Return6.19%

Is QTTB undervalued or overvalued?

QTTB scores 5.26/10 on fundamentals and holds a Fair valuation at present. Backed by its 125.06% ROE, 55.49% net margin, 3.56 P/E ratio, 2.52 P/B ratio, and 147.27% earnings growth, these metrics solidify its Netural investment rating.